Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Attal

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
Cytometry|September 2, 1998
Flow cytometric characterization of proliferating natural killer lymphocytes from bone marrow donors in the mixed lymphocyte reactionM A Sol, M Thomsen, M Durand, et al.
Leukemia|April 1, 1994
Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloidsD Schlaifer, M R Cooper, M Attal, et al.
American Journal of Clinical Pathology|December 1, 1994
Optimization of immunohistochemical detection of P-glycoprotein in chronic lymphoid disordersM Attal, F Bibeau, C Muller, et al.
Pathologie-Biologie|September 1, 1988
[Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin]H Rubie, M Attal, J Lemozy, et al.
Blood|October 1, 1986
t(14;14)(q11;q32) in biphenotypic blastic phase of chronic myeloid leukemiaN Dastugue, E Kuhlein, E Duchayne, et al.
Blood|August 1, 1993
Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trialM Attal, F Huguet, H Rubie, et al.
Journal of Computer Assisted Tomography|November 1, 1994
Rectal malacoplakia in renal transplantation: MR featuresM F Bellin, M A Darchen, C Hoang, et al.
Lancet (London, England)|June 10, 1989
Prevention of acute graft-versus-host disease by monoclonal antibody to interleukin-2 receptorD Blaise, D Maraninchi, C Mawas, et al.
Bone Marrow Transplantation|July 1, 1997
Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantationS J Martin, M A Audrain, F Oksman, et al.
Clinical Rheumatology|December 6, 2005
Do new therapeutic approaches (autotransplants, thalidomide, dexamethasone) improve the survival of patients with multiple myeloma followed in a rheumatology department?S El Mahou, M Attal, B Jamard, et al.
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
Cytometry|September 2, 1998
Flow cytometric characterization of proliferating natural killer lymphocytes from bone marrow donors in the mixed lymphocyte reactionM A Sol, M Thomsen, M Durand, et al.
Leukemia|April 1, 1994
Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloidsD Schlaifer, M R Cooper, M Attal, et al.
American Journal of Clinical Pathology|December 1, 1994
Optimization of immunohistochemical detection of P-glycoprotein in chronic lymphoid disordersM Attal, F Bibeau, C Muller, et al.
Pathologie-Biologie|September 1, 1988
[Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin]H Rubie, M Attal, J Lemozy, et al.
Blood|October 1, 1986
t(14;14)(q11;q32) in biphenotypic blastic phase of chronic myeloid leukemiaN Dastugue, E Kuhlein, E Duchayne, et al.
Blood|August 1, 1993
Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trialM Attal, F Huguet, H Rubie, et al.
Journal of Computer Assisted Tomography|November 1, 1994
Rectal malacoplakia in renal transplantation: MR featuresM F Bellin, M A Darchen, C Hoang, et al.
Lancet (London, England)|June 10, 1989
Prevention of acute graft-versus-host disease by monoclonal antibody to interleukin-2 receptorD Blaise, D Maraninchi, C Mawas, et al.
Bone Marrow Transplantation|July 1, 1997
Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantationS J Martin, M A Audrain, F Oksman, et al.
Clinical Rheumatology|December 6, 2005
Do new therapeutic approaches (autotransplants, thalidomide, dexamethasone) improve the survival of patients with multiple myeloma followed in a rheumatology department?S El Mahou, M Attal, B Jamard, et al.
Pageof 16